Merit Medical Systems reported $985.53M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
3M USD 16.39B 298M Dec/2025
Abbott USD 26B 1.16B Dec/2025
AngioDynamics USD 172.27M 3.09M Feb/2025
Anika Therapeutics USD 101.59M 2.27M Sep/2025
AtriCure USD 322.52M 21.41M Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
ICU Medical USD 1.19B 16.74M Dec/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Medtronic USD 24B 773M Sep/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Olympus JPY 652.65B 47.58B Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
STAAR Surgical USD 321.21M 28.42M Sep/2025
Stryker USD 14.76B 1.04B Dec/2025
Surmodics USD 81.3M 948K Sep/2024
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.99B 262.12M Sep/2025
Terumo JPY 815.56B 71.48B Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025